Newborn Acquisition Corp.
Status: Deal Closed
U=S+W+R
W=S/2@11.5
R=S/10
| IPO Proceeds, $M | $57.50M |
|---|---|
| IPO Date | Feb 14, 2020 |
| CEO | Wenhui Xiong |
| Left Lead | Chardan |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 12 months + (3*2) |
| IPO Sector |
General
Asia (excluding China) |
| IPO Geography | Asia |
| Target Company | Nuvve |
| Deal Announced | Nov 12, 2020 |
| Deal Size, $M | $131.60M |
| Deal Sector | Automotive |
| Deal Geography | Global |
| SEC Filings | www.sec.gov |
| Approval Vote | Mar 17, 2021 |
| Amendment Vote | TBD |
| Closing Date | Mar 22, 2021 |
Formerly NBAC
NVVE
NVVEW
| Price | $3.60 $0.01 |
|---|---|
| Last closing price | $3.28 |
| H/L, today | $3.22 / $3.33 |
| H/L, 52-week | $0.13 / $2.64 |
| Volume, today | 5,855 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Newborn Acquisition Corp.:
- Structure and cap table
- 5 directors & officers
- 26 filings and events
- 2 underwriters
- 3 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Wenhui Xiong | 39 | Chairman and Chief Executive Officer |
| Jianjun Nie | 37 | Chief Financial Officer and Director |
| H. David Sherman | 71 | Independent Director |
| Jianzhong Lu | 65 | Independent Director |
| Li Wan | 51 | Independent Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Chardan | BR | 4,950,000 | units |
| B. Riley FBR | 50,000 | ||
| 5,000,000 | units | ||
| Up-Front UW fee | 3.00 | % | |
| Deferred UW fee |
2.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.